hyaluronoglucosaminidase has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, H; Anderson-Smits, C; Ay, H; Bar, M; Brannagan, TH; Bril, V; Chroni, E; Duff, K; Greco, E; Hadden, RDM; Hasan, S; Latov, N; Levine, T; Li, Z; Pasnoor, M; Rejdak, K; Rivero, A; Sacconi, S; Souayah, N; Yel, L | 1 |
1 trial(s) available for hyaluronoglucosaminidase and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
Topics: Adult; Female; Humans; Hyaluronoglucosaminidase; Immunoglobulins, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome | 2023 |